ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04621	NOD-like receptor signaling pathway	22/221	157/7206	1.81142530238e-09
ko04217	Necroptosis	21/221	178/7206	9.51383838346e-08
ko05164	Influenza A	20/221	167/7206	1.52264364679e-07
ko04060	Cytokine-cytokine receptor interaction	21/221	191/7206	3.20118522149e-07
ko04210	Apoptosis	20/221	180/7206	5.23084597334e-07
ko04380	Osteoclast differentiation	17/221	134/7206	5.94714915029e-07
ko00643	Styrene degradation	4/221	4/7206	8.61589110006e-07
ko04657	IL-17 signaling pathway	13/221	87/7206	2.04926273374e-06
ko04668	TNF signaling pathway	15/221	120/7206	3.37844390139e-06
ko00350	Tyrosine metabolism	8/221	33/7206	4.93764086438e-06
ko05133	Pertussis	12/221	87/7206	1.19546051661e-05
ko00140	Steroid hormone biosynthesis	8/221	41/7206	2.74944542764e-05
ko04620	Toll-like receptor signaling pathway	12/221	100/7206	4.98157836263e-05
ko05204	Chemical carcinogenesis	8/221	48/7206	9.02508484799e-05
ko04622	RIG-I-like receptor signaling pathway	9/221	62/7206	0.00010054087437
ko05145	Toxoplasmosis	13/221	126/7206	0.000118762580718
ko04064	NF-kappa B signaling pathway	11/221	96/7206	0.000156763170408
ko00980	Metabolism of xenobiotics by cytochrome P450	7/221	40/7206	0.000182506867579
ko05160	Hepatitis C	14/221	153/7206	0.00023645012188
ko05418	Fluid shear stress and atherosclerosis	15/221	173/7206	0.000257427244561
ko05161	Hepatitis B	15/221	173/7206	0.000257427244561
ko04080	Neuroactive ligand-receptor interaction	2/221	423/7206	0.000358365505883
ko05134	Legionellosis	9/221	74/7206	0.000398233192385
ko01524	Platinum drug resistance	9/221	76/7206	0.000486807943663
ko04624	Toll and Imd signaling pathway	7/221	49/7206	0.000665364098167
ko05168	Herpes simplex infection	14/221	182/7206	0.0013536640132
ko04623	Cytosolic DNA-sensing pathway	6/221	41/7206	0.00142309814228
ko00360	Phenylalanine metabolism	4/221	17/7206	0.00149590524556
ko05152	Tuberculosis	14/221	187/7206	0.00175262578686
ko05142	Chagas disease (American trypanosomiasis)	11/221	130/7206	0.00207652436435
ko04215	Apoptosis - multiple species	6/221	47/7206	0.00291713107562
ko00982	Drug metabolism - cytochrome P450	5/221	37/7206	0.00507593885327
ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2/221	4/7206	0.0053935680771
ko00480	Glutathione metabolism	6/221	55/7206	0.00643017119593
ko04142	Lysosome	11/221	151/7206	0.00655267100499
ko04630	Jak-STAT signaling pathway	10/221	132/7206	0.00717233507855
ko04115	p53 signaling pathway	7/221	74/7206	0.0073083194788
ko05167	Kaposi's sarcoma-associated herpesvirus infection	13/221	191/7206	0.00814112422746
ko00830	Retinol metabolism	5/221	42/7206	0.00875431690465
ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2/221	5/7206	0.0088080054404
ko05131	Shigellosis	7/221	82/7206	0.0125775107939
ko04917	Prolactin signaling pathway	7/221	87/7206	0.0170141817913
ko04662	B cell receptor signaling pathway	7/221	88/7206	0.0180191405635
ko00120	Primary bile acid biosynthesis	3/221	20/7206	0.0220687291144
ko05120	Epithelial cell signaling in Helicobacter pylori infection	7/221	92/7206	0.0224578006523
ko00740	Riboflavin metabolism	2/221	8/7206	0.0232075371886
ko04930	Type II diabetes mellitus	5/221	54/7206	0.0242426101596
ko00520	Amino sugar and nucleotide sugar metabolism	5/221	55/7206	0.0260238540561
ko05140	Leishmaniasis	6/221	75/7206	0.0270207911927
ko04932	Non-alcoholic fatty liver disease (NAFLD)	11/221	182/7206	0.0271826876093
ko05132	Salmonella infection	7/221	98/7206	0.0304525304588
ko00401	Novobiocin biosynthesis	1/221	1/7206	0.0306688870386
ko05162	Measles	8/221	120/7206	0.0307688403079
ko05146	Amoebiasis	7/221	99/7206	0.0319494915233
ko04062	Chemokine signaling pathway	12/221	201/7206	0.0336820985293
ko05034	Alcoholism	2/221	238/7206	0.0351435903512
ko00950	Isoquinoline alkaloid biosynthesis	2/221	10/7206	0.0358255673108
ko04931	Insulin resistance	9/221	137/7206	0.0380935049836
ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2/221	11/7206	0.0429173100014
ko04723	Retrograde endocannabinoid signaling	1/221	175/7206	0.0452822425031